Ben Ghorbel I, Ibn Elhadj Z, Khanfir M, Houman M H
Service de médecine interne, hôpital La Rabta, 1007 Tunis.
Arch Mal Coeur Vaiss. 2004 Dec;97(12):1195-9.
Pulmonary involvement in Behcet's disease is uncommon and pulmonary arterial aneurysms are present in about 1 to 7% of patients. But despite their scarcity, they represent a life-threatening complication and are usually regarded as of a poor prognosis. Our study aims to describe the epidemiological and therapeutic aspects of this condition. Among 180 patients with Behcet's disease according to the criteria of the international study group for Behcet's disease, four were diagnosed as having pulmonary artery aneurysms (2.22%). All were male, the mean age at the time of the diagnosis of pulmonary artery aneurysms was 29.8 years and the mean disease duration was 6.6 years. Hemoptysis was the presenting symptom in all cases. The patients were treated by corticosteroid, colchicine and cyclophosphamide pulses. The outcome was good with disappearance of hemoptysis in all cases and disappearance of pulmonary aneurysms in three. One patient had recurrence of aneurysms 40 months after the first episode and died 18 months later. So, we can hope, thanks to medical treatment, a better outcome than previously reported in this complication.
白塞病的肺部受累并不常见,肺动脉瘤在约1%至7%的患者中出现。但尽管其少见,它们却是一种危及生命的并发症,通常被认为预后不良。我们的研究旨在描述这种疾病的流行病学和治疗方面。在按照白塞病国际研究组标准诊断的180例白塞病患者中,有4例被诊断为患有肺动脉瘤(2.22%)。所有患者均为男性,诊断肺动脉瘤时的平均年龄为29.8岁,平均病程为6.6年。咯血是所有病例的首发症状。患者接受了糖皮质激素、秋水仙碱和环磷酰胺脉冲治疗。结果良好,所有病例咯血消失,3例肺动脉瘤消失。1例患者在首次发作40个月后动脉瘤复发,18个月后死亡。因此,得益于医学治疗,我们可以期望在这种并发症方面获得比先前报道更好的结果。